The Priority Review

Tag

JNJ-99245354

1 story

  1. Clinical trials

    Intra-Cellular Therapies registers JNJ-99245354 (ITI-1284) in generalized anxiety disorder

    This study was first posted on ClinicalTrials.gov on October 2, 2026. The trial plans to enroll 705 participants and has a planned start date of September 30, 2026, with a primary completion date of September 20, 2030.